DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2239311/enfusion-inc-enfn-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2239311 Mar 12, 2024 - The headline numbers for Enfusion, Inc. (ENFN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0

https://www.zacks.com/stock/news/2239305/everest-group-eg-s-technical-outlook-is-bright-after-key-golden-cross?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2239305 Mar 12, 2024 - Is it a good or bad thing when a stock experiences a golden cross technical event? 0

https://www.zacks.com/stock/news/2239194/brokers-suggest-investing-in-keycorp-key-read-this-before-placing-a-bet?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2239194 Mar 12, 2024 - The average brokerage recommendation (ABR) for KeyCorp (KEY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock? 0

https://www.zacks.com/stock/news/2239212/kohl-s-kss-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2239212 Mar 12, 2024 - Although the revenue and EPS for Kohl's (KSS) give a sense of how its business performed in the quarter ended January 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. 0

https://www.zacks.com/stock/news/2239213/compared-to-estimates-adm-adm-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2239213 Mar 12, 2024 - Although the revenue and EPS for ADM (ADM) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. 0

https://www.zacks.com/stock/news/2239214/here-s-what-key-metrics-tell-us-about-igt-igt-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2239214 Mar 12, 2024 - Although the revenue and EPS for IGT (IGT) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. 0

https://www.cnbc.com/2024/03/11/a-key-inflation-reading-is-due-out-tuesday-morning-heres-what-to-expect.html Mar 11, 2024 - On a year-over-year basis, headline inflation is expected to show a 3.1% gain and core inflation a 3.7% increase in February. 0

https://www.zacks.com/stock/news/2238939/global-partners-lp-glp-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2238939 Mar 11, 2024 - Global Partners LP (GLP) reachead $46.68 at the closing of the latest trading day, reflecting a -1.66% change compared to its last close. 0

https://www.zacks.com/stock/news/2238945/rockwell-medical-rmti-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2238945 Mar 11, 2024 - Rockwell Medical (RMTI) concluded the recent trading session at $1.54, signifying a +1.32% move from its prior day's close. 0

https://www.zacks.com/stock/news/2238916/rtx-rtx-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2238916 Mar 11, 2024 - RTX (RTX) reachead $91.40 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close. 0